IP Library Granted Patent US 10,653,821
Granted Patent B2
US 10,653,821 · App. 15/768,400 · Granted May 19, 2020

Haemostatic device

Inventor: John Benjamin Nichols (Grantham, GB)
Assignee: SELENTUS SCIENCE LIMITED
A61L31/146A61F13/00021A61L15/425A61L15/64A61L31/148A61L31/16A61F2013/00463A61L15/32A61L2300/418A61L2400/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,821
App. No.
15/768,400
Granted
May 19, 2020
Kind
B2
Abstract

A bioresorbable haemostatic foam sponge for adhering to a wound. The sponge has a tissue-contacting surface divided into a plurality of closely-spaced tissue contacting elements. Also disclosed are methods for forming the haemostatic sponge and methods of using the sponge.

Claims (22)

1. A bioresorbable haemostatic foam sponge for adhering to a wound, the sponge comprising a tissue-contacting surface configured to contact the wound, which surface is divided into a plurality of closely-spaced tissue contacting elements such that there are at least 10 tissue contacting elements per 100 mm 2 of tissue-contacting surface,

wherein the sponge is manufactured from collagen, starch, gelatin or hyaluronic acid, and

wherein the tissue-contacting elements are columnar, the cross-sectional area of each tissue-contacting element is consistent throughout the depth of the tissue-contacting element, and the cross-sectional area of each face of each tissue contacting element is 50 mm 2 or less.

2. The haemostatic sponge according to claim 1 wherein each tissue contacting element has a depth of at least 2 mm.

3. The haemostatic sponge according to claim 1 , wherein each tissue contacting element has a depth of 10 mm or less.

4. The haemostatic sponge according to claim 1 , wherein the depth of each tissue contacting element is 80% or less of the depth of the sponge.

5. The haemostatic sponge according to claim 1 , wherein the cross-sectional shape of each tissue contacting element is substantially rectangular.

6. The haemostatic sponge according to claim 1 , wherein each face of each tissue contacting element has a cross-sectional area of 25 mm 2 or less.

7. The haemostatic sponge according to claim 1 , wherein the maximum cross-sectional linear dimension of each tissue contacting element is 10 mm or less.

8. The haemostatic sponge according to claim 1 , wherein the maximum cross-sectional linear dimension is two times or less than the depth of the tissue contacting element.

9. The haemostatic sponge according to claim 1 , wherein the tissue contacting elements are arranged such that each tissue contacting element is within 1 mm of another tissue contacting element.

10. The haemostatic sponge according to claim 1 , wherein the sponge has pores with a diameter of 3 mm or less.

11. The haemostatic sponge according to claim 1 which comprises an immobilised haemostatic agent.

12. The haemostatic sponge according to claim 11 , wherein the haemostatic agent comprises a clotting factor.

13. The haemostatic sponge according to claim 11 , wherein the haemostatic agent further comprises carriers on which a plurality of fibrinogen-binding peptides is immobilised.

14. The haemostatic sponge according to claim 1 , comprising reactive chemical groups that can react to form covalent bonds when contacted with tissue.

15. The haemostatic sponge according to claim 1 in which the tissue contacting elements have been formed by cutting or incising a surface of a sponge.

16. The haemostatic sponge according to claim 1 , wherein the sponge is manufactured from gelatin.

17. The haemostatic sponge according to claim 1 , wherein the tissue contacting elements are arranged such that each tissue contacting element is within 0.1 mm of another tissue contacting element.

18. The haemostatic sponge according to claim 1 , wherein at least 50% of the pores have a diameter between 1 and 1500 μm.

19. A method for forming the haemostatic sponge according to claim 1 , comprising cutting or embossing a surface of a haemostatic sponge.

20. A method of controlling bleeding, comprising administering the haemostatic sponge according to claim 1 , to a wound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2018
From: NICHOLS, JOHN BENJAMIN
To: SELENTUS SCIENCE LIMITED
Reel/Frame 045537/0859 →
Priority Claims (1)
GB 1518182.9 · Oct 14, 2015 · national
Continuity (1)
Related Publication 20180303980A1 · Oct 25, 2018
Cited By (2)
US 12,290,655 US 12,458,540